Search - tctmd.com

Displaying 321 - 340 of 504

Sort: Relevancy | Date

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

ILUMIEN 3: OCT Imaging Matches IVUS but Fails To Beat Angiography for Stent Guidance in PCI

News Conference News TCT 2016

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Shelley Wood

October 30, 2016

News Industry News

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

October 27, 2016

News Opinion Editor's Corner ESC 2016

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Shelley Wood

September 08, 2016

News Conference News ESC 2016

Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18

Todd Neale

August 30, 2016

News Conference News ESC 2016

NORSTENT: Do Modern-day Bare-Metal Stents Stand Up to Drug-Eluting Stents?

Shelley Wood

August 30, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Daily News

Drug Company Payments to Physicians May Be Influencing Prescribing

Todd Neale

August 23, 2016

News Opinion Fellow Talk

Top 10 Tricks for Choosing the Right Stent

Yael L. Maxwell

August 20, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Daily News

Smoked Out: Financial Incentives Prove Effective in Weaning People Off Cigarettes

Yael L. Maxwell

August 15, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients

Todd Neale

July 29, 2016

News Daily News

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Shelley Wood

July 20, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Industry News

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

July 11, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

When Industry Pays for Meals, Physicians Are More Likely to Prescribe Certain Brand-name Drugs

Caitlin E. Cox

June 22, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

Advertisement

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18

NORSTENT: Do Modern-day Bare-Metal Stents Stand Up to Drug-Eluting Stents?

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Drug Company Payments to Physicians May Be Influencing Prescribing

Top 10 Tricks for Choosing the Right Stent

The Bioresorbable Stent Story So Far: What Promise? What Price?

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Smoked Out: Financial Incentives Prove Effective in Weaning People Off Cigarettes

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

When Industry Pays for Meals, Physicians Are More Likely to Prescribe Certain Brand-name Drugs

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content